Drug Discovery & DDS– category –

▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report October 04, 2026 (PDF) — Download Weekly Report October 04, 2026 (PDF) — DownloadDownload 🎙 Podcast October 0...

Psychiatric Times USA Overview Teva Pharmaceutical Industries announced positive post-hoc data from its Phase 3 SOLARIS study of subcutaneous olanzapine (TEV-'749), confirming consistent long-term efficacy and safety for schizophrenia. C...

Pharma Journal India Overview Biocon Biologics' pertuzumab biosimilar, "Pebrilzo," for HER2-positive breast cancer, received a positive opinion recommending marketing authorization from the European Medicines Agency's (EMA) Committee for...

TradingView USA Overview Ionis Pharmaceuticals announced that its FUS-ALS treatment, ulefnersen, met its primary endpoint in the Phase III FUSION trial, signaling a potential breakthrough for this devastating neurodegenerative disease. C...

UF Health USA Overview University of Florida College of Pharmacy researchers identified the marine cyanobacterial genus Dapis as the natural source of dolastatin 15, a potent anticancer compound. This research marks the first genomic cha...

VCBeat China Overview Early clinical data presented at WCLC 2026 revealed that a combination therapy of a PD-(L)1×VEGF bispecific antibody and an ADC, developed by a Chinese firm, achieved an 87.5% objective response rate (ORR) in small ...

Apps Script USA Overview Clinical data reviews have confirmed the effectiveness of oral GLP-1 receptor agonists in significantly lowering HbA1c levels and inducing modest weight loss. Crucially, strict adherence to pre-dosing fasting pro...

DistilINFO USA Overview Stanford University School of Medicine researchers have unveiled a test of 'Virtual Biotech,' an innovative operational model where thousands of AI agents simulate the entire drug discovery workflow. This project ...

Biomedical Science Letters South Korea Overview Novartis' investigational siRNA therapeutic, olpasiran, demonstrated remarkable efficacy in the Phase 2b OCEAN(a)-DOSE trial, reducing lipoprotein(a) (Lp(a)) levels by over 95% at high dose...

MIT News USA Overview MIT researchers have developed a novel lipid nanoparticle (LNP) manufacturing technique that precisely controls particle size and shape, critical for targeted RNA drug delivery. This innovation significantly enhance...